다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Coeptis Therapeutics Holdings Inc (COEP)
Coeptis Therapeutics Holdings Inc (COEP) 뉴스

COEP

Coeptis Therapeutics (COEP)

Coeptis Therapeutics Holdings Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:COEP

1

일자	시간	출처	헤드라인	심볼	기업
2024/05/02	21:47	PR Newswire (US)	Coeptis Therapeutics Announces Poster Data Presentation at American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting	NASDAQ:COEP	Coeptis Therapeutics Holdings Inc
2024/04/02	21:47	PR Newswire (US)	Coeptis Therapeutics Congratulates Alexander Deiters, Professor at the University of Pittsburgh, on Receiving the 2024 Chancellor's Distinguished Research Award	NASDAQ:COEP	Coeptis Therapeutics Holdings Inc
2024/02/26	23:00	PR Newswire (US)	Coeptis Therapeutics Adds Autoimmune Indications to Exclusive License Agreement with University of Pittsburgh for SNAP-CAR T and SNAP-CAR NK	NASDAQ:COEP	Coeptis Therapeutics Holdings Inc
2024/02/07	21:30	PR Newswire (US)	Coeptis Therapeutics to Pursue Phase 2 Program Using Proprietary First-in-Class Allogeneic NK Cell Therapy for the Treatment of Viral Infections	NASDAQ:COEP	Coeptis Therapeutics Holdings Inc
2024/01/04	21:30	PR Newswire (US)	Coeptis Therapeutics President and CEO Issues Letter to Shareholders Highlighting 2023 Accomplishments and Outlook for 2024	NASDAQ:COEP	Coeptis Therapeutics Holdings Inc
2023/10/31	22:01	PR Newswire (US)	Coeptis Therapeutics Announces Research Demonstrating the Potential of SNAP-CAR T-cells to Reduce Tumor Burden and Growth in HER2 and CD20 Expressing Cancers Will be Presented at SITC 2023	NASDAQ:COEP	Coeptis Therapeutics Holdings Inc
2023/10/24	21:30	PR Newswire (US)	Coeptis Therapeutics Announces $2 Million Private Placement	NASDAQ:COEP	Coeptis Therapeutics Holdings Inc
2023/10/11	20:30	PR Newswire (US)	Coeptis Therapeutics Expands License Agreement with University of Pittsburgh to Include SNAP-CAR NK Cell Technology	NASDAQ:COEP	Coeptis Therapeutics Holdings Inc
2023/10/09	22:15	PR Newswire (US)	Coeptis Therapeutics to Participate in Panel at the BioFlorida Conference Discussing Emerging Cell and Gene Therapies	NASDAQ:COEP	Coeptis Therapeutics Holdings Inc
2023/10/04	20:30	PR Newswire (US)	Coeptis Therapeutics Announces Research Involving SNAP-CAR Accepted for Presentation at the Society for Immunotherapy of Cancer's 38th Annual Meeting	NASDAQ:COEP	Coeptis Therapeutics Holdings Inc
2023/09/27	20:30	PR Newswire (US)	Coeptis Therapeutics to Present at the 2023 Cell & Gene Meeting on the Mesa	NASDAQ:COEP	Coeptis Therapeutics Holdings Inc
2023/09/14	20:30	PR Newswire (US)	Coeptis Therapeutics Provides Safety and Dosing Update from Phase 1 Trials Investigating DVX201 in Relapsed/Refractory AML or High Risk MDS and Hospitalized COVID-19 Infection	NASDAQ:COEP	Coeptis Therapeutics Holdings Inc
2023/09/11	20:30	PR Newswire (US)	Coeptis Therapeutics Announces Deverra Therapeutics Has Received Two Life Science Start-Up and Development Awards and Associated Grant from Washington's Cancer Research Endowment	NASDAQ:COEP	Coeptis Therapeutics Holdings Inc
2023/08/31	02:00	PR Newswire (US)	Coeptis Therapeutics Appoints Colleen Delaney, MD, as Chief Scientific and Medical Officer	NASDAQ:COEP	Coeptis Therapeutics Holdings Inc
2023/08/17	20:30	PR Newswire (US)	Coeptis Therapeutics Completes Exclusive License for Allogeneic Immuno-Oncology Platform and Clinical Stage Assets from Deverra Therapeutics	NASDAQ:COEP	Coeptis Therapeutics Holdings Inc
2023/08/01	21:00	PR Newswire (US)	Coeptis Therapeutics Files FDA 513(g) Submission for CD38 In Vitro Companion Diagnostic	NASDAQ:COEP	Coeptis Therapeutics Holdings Inc
2023/06/17	05:00	PR Newswire (US)	Coeptis Therapeutics Holdings, Inc. Announces Closing of $3.5 Million Underwritten Offering	NASDAQ:COEP	Coeptis Therapeutics Holdings Inc
2023/06/14	22:28	PR Newswire (US)	Coeptis Therapeutics Holdings, Inc. Announces Pricing of $3.5 Million Underwritten Offering	NASDAQ:COEP	Coeptis Therapeutics Holdings Inc
2023/06/09	20:00	PR Newswire (US)	Coeptis Therapeutics Receives Approval to Transfer to The Nasdaq Capital Market	NASDAQ:COEP	Coeptis Therapeutics Holdings Inc
2023/05/17	21:30	PR Newswire (US)	Coeptis Therapeutics Appoints Brian Cogley as Chief Financial Officer	NASDAQ:COEP	Coeptis Therapeutics Holdings Inc
2023/05/11	04:00	PR Newswire (US)	Coeptis Therapeutics' SNAP-CAR Technology Platform for Programmable Antigen Targeting Featured in Peer-Reviewed Article in Nature Communications	NASDAQ:COEP	Coeptis Therapeutics Holdings Inc
2023/04/18	20:30	PR Newswire (US)	Coeptis Therapeutics Signs Agreement to Acquire Allogeneic Immuno-Oncology NK Platform in Phase 1 Clinical Trials from Deverra Therapeutics	NASDAQ:COEP	Coeptis Therapeutics Holdings Inc
2023/03/29	22:45	PR Newswire (US)	Coeptis Therapeutics Secures Exclusive Rights to Negotiate to Acquire Transformational Cell Therapy Platform to Enable Potent Combinatorial Immuno-Oncology Treatment Strategies	NASDAQ:COEP	Coeptis Therapeutics Holdings Inc
2023/03/21	20:00	PR Newswire (US)	Coeptis Therapeutics' SNAP-CAR Technology Platform Highlighted in Peer-Reviewed Article in Translational Medicine	NASDAQ:COEP	Coeptis Therapeutics Holdings Inc
2023/02/07	22:00	PR Newswire (US)	Coeptis Therapeutics and ShareIntel Enter Shareholder Service Agreement, Targeting Illegal Short Selling	NASDAQ:COEP	Coeptis Therapeutics Holdings Inc
2023/01/31	22:45	PR Newswire (US)	Coeptis Therapeutics Enters into Sponsored Research Agreement with the University of Pittsburgh to Advance SNAP-CAR Development Program	NASDAQ:COEP	Coeptis Therapeutics Holdings Inc
2022/11/22	21:00	PR Newswire (US)	Coeptis Therapeutics Engages IQVIA to Support SNAP-CAR Development Program	NASDAQ:COEP	Coeptis Therapeutics Holdings Inc
2022/11/15	21:00	PR Newswire (US)	Coeptis Therapeutics Holdings to Ring the Nasdaq Stock Market Opening Bell	NASDAQ:COEP	Coeptis Therapeutics Holdings Inc
2022/11/08	21:00	PR Newswire (US)	Coeptis Therapeutics' Scientific Advisory Board Members Featured on "Biology of Natural Killer (NK) Cells" Podcast	NASDAQ:COEP	Coeptis Therapeutics Holdings Inc
2022/11/02	20:00	PR Newswire (US)	Coeptis Therapeutics Holdings Expands Board of Directors with New Appointments	NASDAQ:COEP	Coeptis Therapeutics Holdings Inc

검색 관련기사 보기:NASDAQ:COEP

1

BNP Paribas (QX)

Bank of America

Invesco QQQ Trust Series 1

Verizon Communications

US Dollar vs Euro

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관